Denali Therapeutics Inc. (DNLI)
CA
Total Compensation for Fiscal Year Ending in 2022: $9,284,688
| Salary | $645,000 |
|---|---|
| Bonus | $387,000 |
| Value of Stock Awards | $2,930,740 |
| Value of Option Awards | $5,309,748 |
| Non-Equity Incentive Plan Compensation | $0 |
| Change in Pension Value and Deferred Compensation Earnings | $0 |
| All Other Compensation | $12,200 |
| Total | $9,284,688 |
Denali Therapeutics Inc. disclosed its CEO pay was
31
times its median employee's pay for the fiscal year ending in 2022.
How Do You Compare?
